
Senior Director, Pfizer
New London/Norwich, Connecticut Area

Senior Director, Pfizer
New London/Norwich, Connecticut Area
Chris L. Waller, Ph.D. is the Senior Director of Precompetitive Collaborations in Worldwide Technology at Pfizer, Inc., where his interest is in the development of collaborations between pharmaceutical, biotechnology, technology, academic, and government organizations to develop and promote the use of standards, identify partnerships, and transfer technology in order to drive greater process efficiency and lower costs. Waller has a Doctorate in Medicinal Chemistry and Natural Products from the University of North Carolina-Chapel Hill and a Bachelors of Science in Pre-medical Studies from Davidson College.
In his current role, Waller is spearheading a new initiative within Pfizer that consists of three primary elements: (1) the definition and promotion of industry standards (e.g., data models, APIs, processes, etc.) across the Research and Development and Medical continuum through participation on various cross-pharmaceutical company entities (e.g., Waller is a Senior Core Member of the Pistoia Alliance, Inc.); (2) proactive pursuit of pre/non-competitive collaborative application or technology development opportunities (e.g., industry partnerships focused on the development of commodity applications or services); and (3) identification and cultivation of opportunities to generate revenue by monetizing Pfizer’s portfolio of products and services (e.g., divestment and/or licensing of Pfizer-developed applications).
He was previously Worldwide Head of Chemistry Informatics at Pfizer where he was responsible for the strategic direction of the IT portfolio of products and services in support of enterprise chemical and biological data access and analysis as well as medicinal chemistry compound design and synthesis. Prior to joining Pfizer, Waller held various positions at Eli Lilly and Company (Sphinx Laboratories), OSI Pharmaceuticals, Inc. and the U.S. Environmental Protection Agency.
technology assessment, vendor negotiation, drug discovery, laboratory automation, robotics, informatics systems, technology transfer, academic relationships
(Public Company; PFE; Pharmaceuticals industry)
January 2009 — Present (11 months)
Develop collaborations between pharmaceutical, biotechnology, technology, academic, and government organizations in precompetitive space to develop and promote the use of standards, identify partnerships, and transfer technology in order to drive greater process efficiency and lower costs.
(Public Company; PFE; Pharmaceuticals industry)
December 2005 — December 2008 (3 years 1 month)
Provided strategic, scientific, and technical direction for a global multi-site informatics and computational chemistry group engaged in the developing and supporting worldwide research at Pfizer. Participated in development of Pfizer chemistry strategy as a member of the discovery chemistry leadership team. Participated as a member of the research informatics leadership team and the research informatics board, and was directly responsible for setting strategy for chemistry and screening informatics operations.
(Public Company; PFE; Pharmaceuticals industry)
November 2001 — November 2005 (4 years 1 month)
Provided management of a group of business analysts and information technology professionals engaged in delivering and supporting discovery research and development activities. Participated as a member of the site leadership team, and was responsible for development of IT strategy and implementation of products and services to support therapeutic area project teams.
(Information Technology and Services industry)
1999 — 2001 (2 years )
Identified and implemented desktop and server side products for integration into lead generation chemistry intranet. Provided computational chemistry expertise in support of lead generation and lead optimization combinatorial chemistry efforts. Research projects focused on the development and application of computational algorithms for use in combinatorial library design, quantitative structure-activity relationship (QSAR) modeling of pharmacological and toxicological properties of compounds, and diversity analysis to compare chemical libraries.
(Pharmaceuticals industry)
1995 — 1999 (4 years )
Responsible for the management and technical direction of a multidisciplinary team involved in the development of informatics data management and robotic systems for high through-put screening and combinatorial chemistry efforts as related to drug discovery. Research projects focused on the development and application of computational algorithms for use in combinatorial library design, quantitative structure-activity relationship (QSAR) modeling of pharmacological and toxicological properties of compounds, and diversity analysis to compare chemical libraries.
Ph.D. , Medicinal Chemistry , 1988 — 1992
Dissertation title "Design, Synthesis, and Biological Evaluation of Agents for the Prevention of Cerebral Edema".
B.S. , Premedicine , 1983 — 1987
American Chemical Society
Distinguished Alumnus Award, School of Pharmacy, University of North Carolina at Chapel Hill, 2006.
Scientific and Technical Achievement Award, United States Environmental Protection Agency, 1997.
Best Paper in Toxicology and Applied Pharmacology Award, Society of Toxicology, 1996.
Special Act Award, Presentation of Endocrine Disruptor Research Efforts to Fred Hansen, Deputy Director, EPA, 1995.
Special Act Award, Development of QSAR Models for Endocrine Disruptors, EPA, 1995.
Ruth and Vernon Taylor Scholarship, Davidson College, 1986-1987.
Alumni Honor Scholarship, Davidson College, 1983-1986.